Literature DB >> 27101937

Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?

Edward K Geissler1, Andreas A Schnitzbauer1, Hans J Schlitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27101937     DOI： 10.1002/lt.24464

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  1 in total

1.  Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines.

Authors:  Hwajung Kim; Kwang-Woong Lee; Seung Cheol Oh; Min-Young Park; Sooin Seo; Xue-Li Jin; Suk Kyun Hong; Kyung Chul Yoon; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Biomed Rep       Date:  2020-10-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.